These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4080)

  • 1. Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests.
    Ekelund LG; Olsson AG; Orö L; Rössner S
    Br Heart J; 1976 Feb; 38(2):155-61. PubMed ID: 4080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
    Keyriläinen O; Uustialo A
    Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metoprolol in angina pectoris. A subacute study with exercise tests and a long-term tolerability study.
    Keyriläinen O; Uusitalo A
    Acta Med Scand; 1976; 199(6):491-7. PubMed ID: 7100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
    Borer JS; Comerford MB; Sowton E
    J Int Med Res; 1976; 4(1):15-22. PubMed ID: 799974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
    Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose related efficacy of betaxolol in combination with nitroglycerin in patients with angina pectoris: a double blind cross-over study.
    Stroobandt R; Kesteloot H
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):299-309. PubMed ID: 6143538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
    Kato K; Niitani H; Kanazawa T; Shimomura K; Toyama S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S154-9. PubMed ID: 2439788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind trial of penbutolol: a new beta-receptor blocking agent in the treatment of angina pectoris.
    Agarwal AK; Ahuja RC; Chandra M; Gupta NN; Hasan M
    J Int Med Res; 1976; 4(6):410-7. PubMed ID: 17557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A; Gregorini L; Valentini R
    Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
    Thadani U; Davidson C; Singleton W; Taylor SH
    Am J Med; 1980 Feb; 68(2):243-50. PubMed ID: 6101934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris.
    Keyriläinen O; Uusitalo A
    Ann Clin Res; 1978 Aug; 10(4):185-90. PubMed ID: 30388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An eighteen months' study of the clinical response to metoprolol, a selective beta1-receptor blocking agent, in patients with angina pectoris.
    Comerford MB; Besterman EM
    Postgrad Med J; 1976 Aug; 52(610):481-6. PubMed ID: 10564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind titrated-dose comparison of metoprolol and propranolol in the treatment of angina pectoris.
    Frick MH; Luurila O
    Ann Clin Res; 1976 Dec; 8(6):385-92. PubMed ID: 795362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
    Klein W; Fluch N; Brandt D
    Wien Klin Wochenschr; 1982 May; 94(10):258-61. PubMed ID: 6126961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of cedilanid-D in combination with metoprolol on exercise tolerance and systolic time intervals in angina pectoris.
    Ekelund LG; Johnsson G; Melcher A; Oro L
    Am J Cardiol; 1976 Mar; 37(4):630-4. PubMed ID: 3961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.
    Salonen JT; Taskinen E; Salonen R; Seppänen K; Venäläinen J; Rauramaa R
    Am J Cardiol; 1986 Nov; 58(12):35E-40E. PubMed ID: 2878600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris.
    Nordenfelt I; Olsson L; Persson S
    Eur J Clin Pharmacol; 1974; 7(3):157-62. PubMed ID: 4152812
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.
    Jackson G; Atkinson L; Oram S
    Br Med J; 1975 Mar; 1(5960):708-12. PubMed ID: 804952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.